Trials / Completed
CompletedNCT03092882
Digital Self-Management Program for Medicare Advantage Members With Type 2 Diabetes- Impact on A1c
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 607 (actual)
- Sponsor
- Evidation Health · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Digital Self-Management Program for Medicare Advantage Members with Type 2 Diabetes - Impact on A1c trial is a 26-week long, prospective, intent-to-treat, 2-arm randomized controlled trial that aims to evaluate the impact of the Digital Self-Management Program on A1c levels for individuals with uncontrolled Type 2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Diabetes Self-Management Program | The Diabetes Self-Management Program is a platform that includes a smart meter, access to coaching 24/7, and a mobile app and website that help members manage their diabetes. The program offers diabetes education and coaching delivered entirely through the smart meter and mobile app or website. |
Timeline
- Start date
- 2017-03-03
- Primary completion
- 2018-02-07
- Completion
- 2018-02-07
- First posted
- 2017-03-28
- Last updated
- 2019-06-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03092882. Inclusion in this directory is not an endorsement.